Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 325–360
- Headlines
- 37603
- Sources here
- 16
- Companies here
- 31
Current section
United States Healthcare news
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …
THC
main company
Sharemaestro market context
Trend signal started
52 weeks +52.4% · Next-week setup positive 55.5%
Trinity Biotech secures $7m from Perceptive Advisors By Investing.com
Trinity Biotech (NASDAQ:TRIB) has secured an additional $7.0 million investment from Perceptive Advisors, its largest financial investor, comprising $2.5 million in new debt and $4.5 million in capitalized interest. This funding will support the company's CGM+ continuous glucose monitoring platform, Trinovium subsidiary, and diagnostics …
TRIB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -74.4% · Next-week setup negative 37.0%
Form 8K Lifeward Ltd. For: 14 August By Investing.com
This article reports on the filing of Form 8K by Lifeward Ltd. on August 14th. It appears to be a standard financial news brief from Investing.com, providing basic information about the filing and its publication details.
LFWD
mentioned
Sharemaestro market context
Trend signal active
52 weeks +1.2% · Next-week setup negative 34.1%
Why Did Oscar Health (OSCR) Fall After Record Profit and a Guidance Hike?
Oscar Health, Inc. (NYSE:OSCR) shares closed 11.9% lower at $26.54 on August 6, even after the insurer reported its most profitable first half and raised its full-year outlook. Second-quarter revenue rose 70% year over year to $4.88 billion, while the company swung to net …
OSCR
main company
Sharemaestro market context
Trend signal active
52 weeks +78.4% · Next-week setup negative 42.2%
Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement
Trinity Biotech (NASDAQ: TRIB) has secured an additional $7.0 million investment from Perceptive Advisors, its largest financial investor, and has regained compliance with Nasdaq's minimum bid price requirement. The investment, consisting of new debt funding and capitalized interest, aims to bolster liquidity for strategic …
TRIB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -74.4% · Next-week setup negative 37.0%
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
Shares of Tenet Healthcare (THC) have been strong performers lately, with the stock up 34.1% over the past month. The stock hit a new 52-week high of $270.57 in the previous session. Tenet has gained 34.4% since the start of the year compared to …
THC
main company
Sharemaestro market context
Trend signal started
52 weeks +52.4% · Next-week setup positive 55.5%
Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?
BioMarin Pharmaceutical (BMRN) is outperforming the Medical sector and its specific industry year-to-date, with a 15.3% return compared to the sector's 3%. The company holds a Zacks Rank #2 (Buy) due to improving analyst sentiment. Cardinal Health (CAH) is another medical stock showing strong …
BMRN
main company
Sharemaestro market context
Trend signal started
52 weeks +10.9%
Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating
Oppenheimer has revised its price target for Abeona Therapeutics (ABEO) to $21 from $22, while reiterating an Outperform rating on the stock. This adjustment comes after Abeona Therapeutics' shares fell following a Q2 earnings miss. The article also provides a company profile, recent news, …
ABEO
main company
Sharemaestro market context
Trend signal active
52 weeks +1.5%
Avoro, Aghazadeh report 7.06% Hemab Therapeutics (COAG) ownership stake
Avoro Capital Advisors LLC, Avoro Ventures LLC, and Behzad Aghazadeh have collectively reported a beneficial ownership stake of 7.06% in Hemab Therapeutics Holdings, Inc. (COAG). This ownership comprises 3,298,236 shares of common stock, acquired solely for investment purposes on behalf of their respective funds. …
COAG
main company
Sharemaestro market context
Stored weekly price path
15 weeks +46.1%
HC Wainwright Has Negative View of Talphera FY2029 Earnings
HC Wainwright has lowered its FY2029 earnings per share estimate for Talphera (NASDAQ:TLPH) to $0.12 from $0.13, while reiterating a "Buy" rating and a $3.00 price target. The firm also projected FY2030 EPS at $0.32. Talphera's stock has a "Hold" consensus rating from analysts, …
TLPH
main company
Sharemaestro market context
Trend signal active
52 weeks +236.2% · Next-week setup negative 38.4%
Crinetics Pharmaceuticals merger with Vertex Pharmaceuticals advances after regulatory clearances
The proposed merger between Crinetics Pharmaceuticals (NASDAQ:CRNX) and Vertex Pharmaceuticals (NASDAQ:VRTX) has progressed after securing regulatory clearances, including the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and approvals in Austria, Germany, and Australia. The acquisition, valued at approximately $10 billion, is expected …
VRTX
main company
Sharemaestro market context
Trend signal active
52 weeks +26.3%
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf
Grabar Law Office is investigating potential breaches of fiduciary duty by officers and directors of ARS Pharmaceuticals, Inc., Bloom Energy Corporation, Erasca, Inc., and Insulet Corporation. The investigations concern various allegations including misleading statements regarding product timelines, supply chain reliance, and manufacturing issues, which …
Sharemaestro market context Price below Trend Line 52 weeks -57.6% · Next-week setup positive 56.7%PDS Biotechnology shareholders approve charter amendment and director elections
PDS Biotechnology Corporation shareholders have approved an amendment to the company's certificate of incorporation, increasing the number of authorized common shares from 150 million to 300 million. They also elected two Class B directors, Kamil Ali-Jackson and Ilian Iliev, and ratified KPMG US LLP …
PDSB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -34.8% · Next-week setup negative 43.3%
Omeros: YARTEMLEA Is Off To A Blistering Start (NASDAQ:OMER)
Omeros Corporation has received a Buy rating due to YARTEMLEA's unexpectedly strong launch, generating $28.5 million in net sales and positive operating cash flow in its first full quarter. The drug's adoption is rapidly increasing across transplant centers, with high formulary approval rates and …
OMER
main company
Sharemaestro market context
Price above Trend Line
52 weeks +200.5%
Twist Bioscience (TWST): EdgePoint discloses 4.21% beneficial stake in amended 13G
EdgePoint Investment Group Inc. has filed an amended Schedule 13G, disclosing a 4.21% beneficial ownership stake in Twist Bioscience Corp (TWST), totaling 2,521,635 shares as of June 30, 2026. The filing indicates EdgePoint acts as an investment manager for various funds that directly own …
TWST
main company
Sharemaestro market context
Trend signal active
52 weeks +311.3%